Initial Neonatal Work-up First urine-will only detect very recent substance use First meconium-will detect substances used after 20 weeks gestation StandardizedNAS.

Slides:



Advertisements
Similar presentations
New Experiences in the CF Clinic Why Do We Do What We Do? Darci Pfeil APNP.
Advertisements

Dr. Amel F. Al-Sayed Asst. Prof. & Consultant Department of Obstetrics & Gynecology.
Preparing for the Predictable Planning for common threats to comfort in the final days. Tamara Wells RN MN CNS Dr. M. Harlos Medical Director WRHA Palliative.
Dosing and patient management requirements during induction, stabilization, and detoxification with buprenorphine Matthew A. Torrington MD Clinical Research.
Effective Risk Management Strategies in Outpatient Methadone Treatment: Clinical Guidelines and Liability Prevention Curriculum Module 9 Special Populations.
Neonatal Abstinence Syndrome: A Family Centered Approach to Care Kelly Outlaw, M.S., CCLS.
Nadin Abdel Razeq, PhD. Objectives To gain awareness of the proper procedure of peripheral IV access in pediatrics To review types of IV fluids used in.
DIARRHEA and DEHYDRATION
Doug Simkiss Associate Professor of Child Health Warwick Medical School Management of sick neonates.
Neonatal Abstinence Syndrome. Risks for developing NAS Opioids – Opiate derivatives, interact with mu-opioid receptor Abstinence syndrome (withdrawal)
Kelly Geraghty, Tracy James, Kristen Lintjer,
Neonatal Abstinence Project Medical Guidelines Committee Kentucky NAS Workgroup Amy Snell.
V.Sideri, C.Vliora, A.Daskalaki, P.Mexi-Bourna, K.Kleanthous, M.Soulioti, G. Kyrkou, N.Bournas, V.Papaevangelou 3 rd Pediatric Clinic of the University.
Neonatal Nursing Care: Part 3 Nursing Care of Normal Newborn
Many Disciplines: One Goal. Care of the Drug Exposed Newborn Kelly Burch, PharmD NICU Conference October 26, 2010 St. John’s Mercy Children’s Hospital.
HIGH RISK NEWBORN: GOALS, CONCEPTS, PRINICPLES, ASSESSMENT
Bell Ringer (3 paragraphs - 5 sentences each)  You're at home watching "CSI" when you hear a faint scratching at the door. Upon opening it, you see a.
Education Guide for Parents and Caregivers. Neonatal Abstinence Syndrome (NAS) NAS may present in a baby who is exposed to medication taken by the mother.
Objectives To produce a healthy, normal weight infant while minimizing the short and long term health risks to the mother To determine the appropriate.
British Guideline on the Management of Asthma. Aims Review of current SIGN/BTS guidelines –Diagnosing Asthma –Stepwise management of Asthma –Managing.
Introduction
Vanderbilt Pediatric Hematology Anticoagulation Guidance Protocol Robert F. Sidonio, Jr. MD, MSc. 4/12/12 Warfarin Monitoring If inpatient, consider monitoring.
Children Birth 4. Childbirth Setting And Attendants 99% of U.S. births occur in hospitals Other options –Freestanding birth center, home delivery Who.
Dr.Zarkesh Neonatologist. Crying:  Is the last sign of hunger.  Is the main route of communication between infants and their parents.  Is the most.
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
©2013 Children's Mercy. All Rights Reserved. 09/13 The Drug Exposed Neonate; Now What? Neonatal Abstinence Syndrome (NAS) Betsy Knappen APRN, BSN, Jodi.
Angela Stein, Pharm.D. PGY-1 Pharmacy Resident St. Johns Mercy Medical Center St. Louis College of Pharmacy.
MATERNAL & NEONATAL WITHDRAWAL SYNDROME BY: Dr. F.Goudarzi Clinical Toxicologist SUMS.
Neonatal Abstinence Syndrome
Neonatal Abstinence Syndrome Lauritz Meyer, MD September 11, 2015 SDPA Conference.
Chapter 3: Measures of Morbidity and Mortality Used in Epidemiology
The Normal Newborn: Needs and Care. Assessment Data: Condition of the Infant Apgar scores at 1 and 5 minutes Resuscitative measures Physical examination.
M ANAGEMENT OF THE O PIATE -E XPOSED N EWBORN AND I MPLICATIONS FOR B REASTFEEDING Bonny Whalen, MD - Medical Director, Newborn Nursery at CHaD/Dartmouth-Hitchcock.
Current Trends In Identifying And Treating Newborns With Withdrawal Syndromes 6/24/2010.
Preterm labor.
Improving Care for Opioid Exposed Newborns September 11, 2006 NNEPQIN Dartmouth Hitchcock Medical Center Anne Johnston, MD Associate Professor of Pediatrics.
Patty Zetterberg, MSN, C-PNP Director, Clinical Operations Medical Practice Management East Tennessee Children’s Hospital Neonatal Abstinence Syndrome.
CLINICAL EFFICACY TESTING for NASAL DRUGS Mary M. Fanning, M.D., Ph.D. Associate Director for Medical Affairs Office of Generic Drugs, FDA June 4, 1999.
The Effect Of Nutritive Versus Non- Nutritive Feeding Methods On Pain Relive For Premature Infants In Prone Position Following Invasive Procedures.
By: Nicole Stevens  A syndrome of drug withdrawal with non- specific signs and symptoms that may occur in babies following in-utero drug exposure. 
1 Systemic Human Exposure of Pimecrolimus and Tacrolimus Following Topical Application Tapash K. Ghosh, Ph.D. Office of Clinical Pharmacology and Biopharmaceutics.
 The ARBs include the following drugs:  azilsartan (Edarbi),candesartan (Atacand), eprosartan (Teveten), irbesartan(Avapro), losartan (Cozaar), olmesartan.
Neonatal Abstinence Syndrome
Introduction to the Child health Nursing and Nutritional Need Lecture 1 1.
The Problem of Neonatal Abstinence Syndrome (NAS) Opiates and Pregnancy.
Magnesium Sulfate in Severe Perinatal Asphyxia: A Randomized, Placebo-Controlled Trial Mushtaq Ahmad Bhat, et al Apr 6, 2009 Presented By: Yasser Al-Garni.
ESOPHAGEAL DIVERTICULUM.  * An esophageal diverticulum is an outpouching of the esophageal wall.
Patient Blood Management Guidelines: Module 6 Neonatal and Paediatrics ANAEMIA a Hb below reference range for age, sex and gestation Ferritin
Neonatal Abstinence Syndrome: Preserving the Infant-Maternal Bond Haneme Idrizi, MD, FAAP Assistant Professor of Pediatrics, University of Texas Health.
Neonatal Abstinence Syndrome
Sucrose in Neonates: Sources of Sweet Errors Pooja Shah, PharmD, BCPPS Clinical Assistant Professor Ernest Mario School of Pharmacy Rutgers University.
Care of the Neonate with Prenatal Opioid Exposure – Advanced Practice
Management of Common Breastfeeding Problems
Medication Assisted Treatment and Pregnancy
Introduction to the Child health Nursing and Nutritional Need
Protein average weight :
BRAIN DEATH IN NEONATES
Department of Obstetrics & Gynecology
High Risk neonatal nursing
The Late Preterm Infant
Medication Assisted Treatment and Pregnancy
Neonatal Abstinence Syndrome
Continue 2-3 hour feedings
SCREENING AND MANAGEMENT OF ASYMPTOMATIC NEWBORNS
WisPQC Standardized Protocol Webinar for NAS/NOWS Initiative
WisPQC Eat, Sleep, Console Webinar for NAS/NOWS Initiative
Continue 2-3 hour feedings
Jonathan Davis, MD Chief of Newborn Medicine
Cholinesterase Inhibitors: Actions and Uses
For PAWWS (> or = 4) or CIWA (> or = 9)
Presentation transcript:

Initial Neonatal Work-up First urine-will only detect very recent substance use First meconium-will detect substances used after 20 weeks gestation StandardizedNAS scoring should begin within 2 to 4 hours of birth and repeated every 2 hours Finnegan Scores –Easy to learn/administer –Promotes standardization/consistent management Assess for other diagnoses as indicated particularly for persistent diarrhea

Supportive Non-Pharmacologic Therapy Up to 30% of patients will require only supportive management (50% at CFDFL) –Finnegan Score < 8 Quiet dim room Swaddling/rocking Frequent feeding Pacifier for excessive sucking Consider hypercaloric formula Frequent diaper changes

Pharmacologic Management of NAS Morphine Oral Solution Indicated when average of 3 consecutive scores >8 Begin pharmacotherapy within 2 to 4 hours of meeting criteria Vomiting and diarrhea with dehydration indicate need for pharmacotherapy even with scores < 8 Delay in initiating pharmacotherapy is associated with increased infant morbidity

Management with Oral Morphine Score:Dose q4 hours 8 – 100.8ml(0.32mg)/kg/day 11 – 131.2ml(0.48mg)/kg/day 14 – 161.6ml(0.64)/kg/day >162.0ml(0.80)/kg/day Use birth weight for all calculations If scores increase or inadequate response within 12 hours consider increasing morphine by 0.4mg/kg/day increments (total 0.16mg/kg/day) Consider phenobarbital if CNS symptoms not controlled

Stabilization and Detoxification Maintain control of symptoms for 24 to 48 hours Wean medications at the same time every day Use average of scores over a 12 to 24 hours ScoresTitration 6 – 8reduce by %10 3 – 5reduce by %15 Discontinue when 0.1ml(0.04mg) q 4 hours for 24 hours –For infants with medical problems or scores persistently >4 dose interval may be increased rather than discontinuing.